Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med

Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med

Submitted by admin on October 14, 2024 - 10:10am
Source: 
Fierce Biotech
News Tags: 
Longboard Pharmaceuticals
Lundbeck
M&A
epilepsy
bexicaserin
Headline: 
Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med
snippet: 

After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is scooping up the biotech for $2.5 billion.

Do Not Allow Advertisers to Use My Personal information